(Q48463266)

11 February 2018

title

Phase II study of procarbazine, CCNU, and vincristine combination chemotherapy in the treatment of malignant brain tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1122488

23 August 2022

1 reference

1 reference

1 reference

10.1002/1097-0142(197505)35:5<1398::AID-CNCR2820350524>3.0.CO;2-C

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1398::AID-CNCR2820350524%3E3.0.CO;2-C

3 October 2023

author name string

P. H. Gutin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1122488

23 August 2022

C. B. Wilson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1122488

23 August 2022

A. R. Kumar

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1122488

23 August 2022

E. B. Boldrey

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1122488

23 August 2022

V. Levin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1122488

23 August 2022

M. Powell

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1122488

23 August 2022

K. J. Enot

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1122488

23 August 2022

language of work or name

English

0 references

publication date

1 May 1975

1 reference

11 February 2018

full work available at URL

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%28197505%2935%3A5%3C1398%3A%3AAID-CNCR2820350524%3E3.0.CO%3B2-C

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1122488

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197505)35:5%3C1398::AID-CNCR2820350524%3E3.0.CO;2-C

3 October 2023

1 reference

10.1002/1097-0142(197505)35:5<1398::AID-CNCR2820350524>3.0.CO;2-C

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1398::AID-CNCR2820350524%3E3.0.CO;2-C

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197505)35:5%3C1398::AID-CNCR2820350524%3E3.0.CO;2-C

3 October 2023

1 reference

10.1002/1097-0142(197505)35:5<1398::AID-CNCR2820350524>3.0.CO;2-C

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1398::AID-CNCR2820350524%3E3.0.CO;2-C

3 October 2023

1 reference

11 February 2018

volume

35

1 reference

11 February 2018

issue

5

1 reference

11 February 2018

page(s)

1398-1404

1 reference

11 February 2018

A PRELIMINARY INVESTIGATION OF THE FATE OF TRITIATED VINBLASTINE IN RATS

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197505%2935%3A5%3C1398%3A%3AAID-CNCR2820350524%3E3.0.CO%3B2-C

Brain extracellular space and the sink action of cerebrospinal fluid. Measurement of rabbit brain extracellular space using sucrose labeled with carbon 14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197505%2935%3A5%3C1398%3A%3AAID-CNCR2820350524%3E3.0.CO%3B2-C

A decade of combination chemotherapy of advanced Hodgkin's disease

21 January 2018

4

1 reference

10.1002/1097-0142(197505)35:5<1398::AID-CNCR2820350524>3.0.CO;2-C

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1398::AID-CNCR2820350524%3E3.0.CO;2-C

3 October 2023

7

32

2593

Frei

1972

1 reference

10.1002/1097-0142(197505)35:5<1398::AID-CNCR2820350524>3.0.CO;2-C

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1398::AID-CNCR2820350524%3E3.0.CO;2-C

Procarbazine hydrochloride in the treatment of brain tumors. Phase 2 study

3 October 2023

10

1 reference

10.1002/1097-0142(197505)35:5<1398::AID-CNCR2820350524>3.0.CO;2-C

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1398::AID-CNCR2820350524%3E3.0.CO;2-C

Effect of vincristine sulphate on the intracranial gliomata of childhood.

3 October 2023

11

1 reference

10.1002/1097-0142(197505)35:5<1398::AID-CNCR2820350524>3.0.CO;2-C

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1398::AID-CNCR2820350524%3E3.0.CO;2-C

SENSITIVITY OF INTRACRANIAL GLIOMAS TO VINCRISTINE SULPHATE

3 October 2023

12

1 reference

10.1002/1097-0142(197505)35:5<1398::AID-CNCR2820350524>3.0.CO;2-C

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1398::AID-CNCR2820350524%3E3.0.CO;2-C

3 October 2023

15

30

2451

Levin

1970

1 reference

10.1002/1097-0142(197505)35:5<1398::AID-CNCR2820350524>3.0.CO;2-C

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1398::AID-CNCR2820350524%3E3.0.CO;2-C

Clinical and Experimental Studies of Fluorescein Dyes with Special Reference to their Use for the Diagnosis of Central Nervous System Tumors

3 October 2023

16

1 reference

10.1002/1097-0142(197505)35:5<1398::AID-CNCR2820350524>3.0.CO;2-C

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1398::AID-CNCR2820350524%3E3.0.CO;2-C

3 October 2023

19

30

1330

Oliverio

1970

1 reference

10.1002/1097-0142(197505)35:5<1398::AID-CNCR2820350524>3.0.CO;2-C

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1398::AID-CNCR2820350524%3E3.0.CO;2-C

INTRA-ARTERIAL VINCRISTINE THERAPY OF PRIMARY GLIOMAS

3 October 2023

21

1 reference

10.1002/1097-0142(197505)35:5<1398::AID-CNCR2820350524>3.0.CO;2-C

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1398::AID-CNCR2820350524%3E3.0.CO;2-C

3 October 2023

25

26

1569

Tator

1966

1 reference

10.1002/1097-0142(197505)35:5<1398::AID-CNCR2820350524>3.0.CO;2-C

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1398::AID-CNCR2820350524%3E3.0.CO;2-C

3 October 2023

Identifiers

10.1002/1097-0142(197505)35:5<1398::AID-CNCR2820350524>3.0.CO;2-C

1 reference

11 February 2018

1 reference

11 February 2018